Testing effectiveness (Phase 2)Looking for participantsNCT06636682
What this trial is testing
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more
Cellvax Therapeutics Inc 100